Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Its appropriate use is confined to legitimate laboratory research contexts
JCI Insight 4 , e126742 (2019)
Effects of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials
Speaking with MNT , Megan Warnke, RDN, a registered dietician nutritionist and Certified Diabetes Care and Education Specialist, also not involved in this research, explained that a very low-calorie diet is not viable approach beyond a short-term intervention: The key words in this study are short term results. Like with any diet, this approach may work for a short period of time, but its not sustainable for long term results. Also, appetite suppression from semaglutide can help patients follow a calorie-restricted diet, but other factors like stress, sleep, and food insecurity will also impact diet success, which is something this drug cant fix, Warnke explained
His unique background and qualifications enable him to provide comprehensive and tailored representation to his clients across various industries
